Why is Aarti Drugs falling/rising?

As of 18-Jul, Aarti Drugs Ltd's stock price is currently at 522.95, reflecting an increase of 7.2, or 1.4%. The stock has shown a positive trend today, having outperformed its sector by 1.95% and reversing a two-day decline. It reached an intraday high of Rs 527, indicating strong performance. Over the past week, the stock has gained 10.42%, while its performance over the past month shows a 17.25% increase. Despite a slight decline of 0.25% over the past year, the stock's management efficiency is highlighted by a high return on capital employed (ROCE) of 17.84%, and institutional investors have increased their stake by 0.9%, suggesting growing confidence in the company's fundamentals.
Broader market context indicates that while Aarti Drugs has outperformed the Sensex in the short term, which has seen a decline of 0.90% over the past week, the stock's long-term growth prospects remain a concern due to modest net sales growth and flat results reported in June. The stock's liquidity appears adequate for trading, although there has been a significant drop in delivery volume, which may suggest reduced investor participation. Overall, the combination of recent positive price movements, institutional interest, and management efficiency contributes to the stock's rising price, despite underlying concerns regarding long-term growth and performance metrics.